Investors in CuraVac invest in a privately held company for the belief they share with all our existing shareholders that our developments for therapeutic vaccines can at the same time bring a wonderful therapeutic breakthrough to patients and be financially rewarding.
Since the beginning of the project, each time we were faced with questions or objections we searched and found an independently proven answer. In doing so, we developed a network of expertise and collaboration around us. This organization as a management company in the center of a competence network is our strength allowing us at the same time to function with the minimum infrastructure and fixed costs and benefitting of the best world experts in the field.
CuraVac finds and optimizes financing but most of all identifies, reduces or even suppresses the risks associated with developing a revolutionary therapeutic approach for the benefits of the patients and the stakeholders.
If you share our goals and hopes, do not hesitate to contact us.